Search by Drug Name or NDC

    NDC 51224-0151-50 Ursodiol 300 mg/1 Details

    Ursodiol 300 mg/1

    Ursodiol is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by TAGI Pharma, Inc.. The primary component is URSODIOL.

    Product Information

    NDC 51224-0151
    Product ID 51224-151_ddcc7cdd-5ea2-41a6-beb1-fdb9a73b5963
    Associated GPIs 52100040000120
    GCN Sequence Number 003095
    GCN Sequence Number Description ursodiol CAPSULE 300 MG ORAL
    HIC3 D7A
    HIC3 Description BILE SALTS
    GCN 01070
    HICL Sequence Number 001370
    HICL Sequence Number Description URSODIOL
    Brand/Generic Generic
    Proprietary Name Ursodiol
    Proprietary Name Suffix n/a
    Non-Proprietary Name Ursodiol
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 300
    Active Ingredient Units mg/1
    Substance Name URSODIOL
    Labeler Name TAGI Pharma, Inc.
    Pharmaceutical Class Bile Acid [EPC], Bile Acids and Salts [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA075517
    Listing Certified Through n/a

    Package

    NDC 51224-0151-50 (51224015150)

    NDC Package Code 51224-151-50
    Billing NDC 51224015150
    Package 100 CAPSULE in 1 BOTTLE (51224-151-50)
    Marketing Start Date 2011-04-15
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.69019
    Pricing Unit EA
    Effective Date 2022-11-23
    NDC Description URSODIOL 300 MG CAPSULE
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis